Levosimendan in patients with low ejection fraction undergoing cardiac surgery.
Conclusions: Levosimendan therapy proved safe in the study group. The nature of the study and the small sample size preclude the formulation of detailed conclusions.
PMID: 29681959 [PubMed]
Source: Polish Journal of Cardio-Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Tags: Kardiochir Torakochirurgia Pol Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | Cardiovascular & Thoracic Surgery | Chronic Kidney Disease | Czechia Health | Heart | Poland Health | Study | Urology & Nephrology | Women